Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2006-07-18
2006-07-18
Jiang, Saojia A. (Department: 1623)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C514S272000, C544S321000, C544S331000
Reexamination Certificate
active
07078410
ABSTRACT:
An aqueous solution for prophylactic treatment of teats of lactating mammals, comprising as a first component at least partially deacetylated chitosan, or an acid addition salt thereof, in a concentration of up to about 2% by weight of chitosan, the solution having a pH of from about 4 to about 6.8, and said first component having a molecular weight such that the viscosity of the solution is less than about 50 mPas; and a method of prophylactic treatment of teats of lactating mammals.
REFERENCES:
patent: 5521184 (1996-05-01), Zimmermann
patent: 5958935 (1999-09-01), Davis et al.
patent: 0233461 (1987-08-01), None
patent: 0379979 (1990-08-01), None
patent: 0114375 (2001-03-01), None
patent: 0220495 (2002-03-01), None
The Merck Manual, Fifteenth Edition, 1989, pp. 2145-2148, pp. 1380-1390; pp. 2141-2146.
Kozlovsky et al, Am. J. Psychiatry, 2000, 157, 831-833.
Imahori et al., J. Biochem. 121, 179-188 (1997).
Vijayaraghavan, et al. Biol. Reprod. 62/6, 1647-54 (2000).
Nikoulina, et al., Diabetes 49/2, 263-71 (2000).
Kozlovsky, et al., Am. J. Psychiatry 157/5, 831-3 (2000).
Gat, et al., Cell 95/5, 605-14 (1998).
Stambolic, et al., Curr. Biol. 6, 1664-1668 (1996).
Klein et al., PNAS 93, 8455-59 (1996).
Hoshi, et al., PNAS 93, 2719-2723 (1996).
Bhat, et al., PNAS 97, 11074-79 (2000).
Cotter, et al., NeuroReport 9, 1379-83 (1998).
Berg Stefan
Bhat Ratan
Hellberg Sven
AstraZeneca AB
Jiang Saojia A.
Krishnan Ganapathy
White & Case LLP
LandOfFree
2-arylamino-pyrimidines for the treatment of GSK3-related... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 2-arylamino-pyrimidines for the treatment of GSK3-related..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 2-arylamino-pyrimidines for the treatment of GSK3-related... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3549522